Sanofi Ventures leads $17m round for Click Therapeutics

Click Therapeutics said today that it landed a $17 million round, led by Sanofi‘s (NYSE:SNY)  venture arm, to fund its platform of prescription digital therapeutics.

The company’s commercial product, Clickotine, is designed to help people quit smoking. The digital smoking cessation program uses a personalized plan to help people overcome tobacco cravings, adhere to medication regimens and connect with people in a support network.

Get the full story at our sister site, Drug Delivery Business News.

The post Sanofi Ventures leads $17m round for Click Therapeutics appeared first on MassDevice.

from MassDevice https://ift.tt/2JLGLVU